Logo Logo

Publications by Saußele, S.

Up a level
Export as [feed] RSS 1.0 [feed] RSS 2.0
Group by: Item Type | Date
Number of items: 5.

Journal article

Richter, J.; Mahon, F. X.; Guilhot, J.; Hjorth-Hansen, H.; Almeida, A.; Janssen, J. J.; Mayer, J.; Porkka, K.; Panayiotidis, P.; Olsson-Strömberg, U.; Berger, M. G.; Diamond, J.; Ehrencrona, H.; Kairisto, V.; Polakova, K. Machova; Müller, M. C.; Mustjoki, S.; Hochhaus, A.; Pfirrmann, M.; Saußele, S. (2016): Stopping tyrosine kinase inhibitors in a very large cohort of European chronic myeloid leukemia patients: results of the euro-ski trial. In: Haematologica, Vol. 101: pp. 22-23

Burchert, A.; Inselmann, S.; Saußele, S.; Dietz, C. T.; Müller, M. C.; Eigendorff, E.; Brendel, C. A.; Metzelder, S. K.; Brümmendorf, T. H.; Waller, C.; Dengler, J.; Goebeler, M. E.; Herbst, R.; Freunek, G.; Stefan, H.; Illmer, T.; Wang, Y.; Lange, T.; Finkernagel, F.; Hehlmann, R.; Huber, M.; Neubauer, A.; Hochhaus, A.; Guilhot, J.; Mahon, F. X.; Pfirrmann, M.; Schütz, C. (2016): Expression of the CTLA-4 ligand CD86 (B7.2) on plasmacytoid dendritic cells (pDC) predicts risk of disease recurrence after treatment discontinuation in chronic myeloid leukemia. In: Oncology Research and Treatment, Vol. 39: p. 39

Voskanyan, A.; Dietz, C. T.; Fabarius, A. C.; Lauseker, M.; Saußele, S.; Kalmanti, L.; Rinaldetti, S.; Haferlach, C.; Pfirrmann, M.; Hasford, J.; Baerlocher, G. M.; Hochhaus, A.; Baccarani, M.; Hehlmann, R. (2016): Major route additional chromosomal aberrations (ACA) precede increase of blasts in chronic myeloid leukemia (CML) independent of therapy. An analysis of CML studies III, IIIA and IV. In: Oncology Research and Treatment, Vol. 39: pp. 52-53

Saußele, S.; Mahon, F.-X.; Guilhot, J.; Dengler, J.; Waller, C. T.; Brümmendorf, T. H.; Herbst, R.; Burchert, A.; Goebeler, M.-E.; Freunek, G.; Prümmer, O.; Jost, P. J.; Prange-Krex, G.; Illmer, T.; Janzen, V.; Schafhausen, P.; Klausmann, M.; Kiani, A.; Eckert, R.; Wit, M. de; Janssen, C.; Müller, M. C.; Hochhaus, A.; Richter, J.; Pfirrmann, M. (2016): Stopping tyrosine kinase inhibitors in a large cohort of European chronic myeloid leukemia (CML) patients: results of the EURO-SKI trial. In: Oncology Research and Treatment, Vol. 39: p. 209

Rinaldetti, S.; Lauseker, M.; Fabarius, A.; Hehlmann, R.; Khaled, N.; Dietz, C. T.; Proetel, U.; Krause, S.; Schubert, J.; Einsele, H.; Hänel, M.; Dengler, J.; Falge, C.; Kanz, L.; Neubauer, A.; Heydrich, B.; Stegelmann, F.; Pfreundschuh, M.; Waller, C. F.; Spiekermann, K.; Baerlocher, G. M.; Pfirrmann, M.; Hofmann, W.-K.; Hochhaus, A.; Müller, M. C.; Saußele, S. (2016): The 3-month velocity of BCR-ABL decline: a tool for predicting deep molecular response in CML patients. In: Oncology Research and Treatment, Vol. 39: p. 222

This list was generated on Sat May 28 07:44:49 2022 CEST.